Scarica l'app Stockscreener
3.43
0.00%
0.00
Precedente Chiudi:
$3.43
Aprire:
$3.48
Volume 24 ore:
187.59K
Relative Volume:
1.09
Capitalizzazione di mercato:
$104.06M
Reddito:
-
Utile/perdita netta:
$-21.24M
Rapporto P/E:
-4.0936
EPS:
-0.8379
Flusso di cassa netto:
$-22.47M
1 W Prestazione:
+31.42%
1M Prestazione:
+34.51%
6M Prestazione:
-37.06%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$3.26
$3.67
Intervallo di 1 settimana:
$2.53
$3.65
Portata 52W:
$2.31
$17.65
Skye Bioscience Inc Stock (SKYE) Company Profile
Nome
Skye Bioscience Inc
Settore
Industria
Telefono
(858) 410-0266
Indirizzo
11250 EL CAMINO REAL, SUITE 100, SAN DIEGO
Confronta SKYE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SKYE
Skye Bioscience Inc.
|
3.10 | 12.89M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.2124 | 454.15M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
GOODO
Gladstone Commercial Corporation
|
20.86 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
2.00 | 85.26M | 0 | 0 | 0 | 0.00 |
|
JUNE
Dhandho Junoon Etf
|
4.00 | 47.74M | 0 | 0 | 0 | 0.00 |
|
DWLD
Davis Select Worldwide ETF
|
38.27 | 0 | 0 | 0 | 0 | 0.00 |
Skye Bioscience Inc Stock (SKYE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-30 | Iniziato | Scotiabank | Sector Outperform |
| 2024-09-10 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-07-09 | Iniziato | Craig Hallum | Buy |
| 2024-05-23 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-04-12 | Iniziato | Oppenheimer | Outperform |
Skye Bioscience Inc Borsa (SKYE) Ultime notizie
(01/30/25) Top Picks 2025: Skye Bioscience (SKYE) - Moneyshow.com
Cantor Fitzgerald Estimates Skye Bioscience FY2025 Earnings - MarketBeat
Cantor Fitzgerald Forecasts Skye Bioscience FY2025 Earnings - Defense World
Cantor Fitzgerald Predicts Skye Bioscience FY2025 Earnings - Defense World
Barclays PLC Has $226,000 Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Barclays PLC Has $226,000 Stock Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Down 2.5%Should You Sell? - MarketBeat
12,200 Shares in Skye Bioscience, Inc. (NASDAQ:SKYE) Acquired by Jane Street Group LLC - Defense World
Jane Street Group LLC Invests $48,000 in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience targets Q4 for obesity drug data - Investing.com India
Skye Bioscience Provides 2025 Look Ahead and Year in Review - The Manila Times
Skye Bioscience Sets Major 2025 Milestones for Revolutionary Obesity Drug Trial - StockTitan
Financial Analysis: Skye Bioscience (NASDAQ:SKYE) vs. VYNE Therapeutics (NASDAQ:VYNE) - Defense World
Geode Capital Management LLC Purchases 15,614 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Acquired by Geode Capital Management LLC - Defense World
Barclays PLC Increases Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Barclays PLC Buys 15,551 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
State Street Corp Acquires 23,201 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
State Street Corp Increases Position in Skye Bioscience, Inc. (NASDAQ:SKYE) - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Down 3% – Should You Sell? - Defense World
Skye Bioscience (NASDAQ:SKYE) Shares Down 3% – Should You Sell? - Defense World
Skye Bioscience (NASDAQ:SKYE) Trading Down 3%Time to Sell? - MarketBeat
Skye Bioscience to Present at J.P. Morgan Healthcare Conference - GlobeNewswire
Skye Bioscience to Present at J.P. Morgan Healthcare Conference 2025: Spotlight on Obesity Treatment Pipeline - StockTitan
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Bought by BNP Paribas Financial Markets - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Shares Purchased by BNP Paribas Financial Markets - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Sees Significant Drop in Short Interest - MarketBeat
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Recommendation of “Buy” from Analysts - Defense World
Skye Bioscience, Inc. (NASDAQ:SKYE) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Skye Bioscience's SWOT analysis: nimacimab's potential in obesity stock market - Investing.com
Point72 Asset Management L.P. Has $1.63 Million Stock Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Skye Bioscience: Nimacimab Targets Safer Weight Loss, Speculative Buy (NASDAQ:SKYE) - Seeking Alpha
Skye Bioscience (NASDAQ:SKYE) Shares Down 12.7%Should You Sell? - MarketBeat
Baker BROS. Advisors LP Purchases 934,634 Shares of Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Baker BROS. Advisors LP Has $5.61 Million Holdings in Skye Bioscience, Inc. (NASDAQ:SKYE) - MarketBeat
Skye Bioscience, Inc. (NASDAQ:SKYE) Short Interest Up 26.8% in November - MarketBeat
Craig-Hallum Initiates Coverage of Skye Bioscience (SKYE) with Buy Recommendation - MSN
Top 10 startups in Ophthalmology in San Diego, United States in Nov, 2024 - Tracxn
Don't Ignore The Insider Selling In Skye Bioscience - Simply Wall St
Skye Bioscience chief development officer sells shares worth $97,721 By Investing.com - Investing.com South Africa
Skye Bioscience chief development officer sells shares worth $97,721 - Investing.com India
Skye Bioscience CEO Punit Dhillon sells $413,924 in stock By Investing.com - Investing.com Nigeria
Skye Bioscience CFO Kaitlyn Arsenault sells $216,652 in stock By Investing.com - Investing.com Australia
Skye Bioscience CFO Kaitlyn Arsenault sells $216,652 in stock - Investing.com India
Skye Bioscience CEO Punit Dhillon sells $413,924 in stock - Investing.com India
Skye Bioscience director Grayson Paul A. sells $432,061 in stock By Investing.com - Investing.com Canada
Skye Bioscience director Grayson Paul A. sells $432,061 in stock - Investing.com
Skye Bioscience Inc Azioni (SKYE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.80%
5.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):